SIRT1 and metabolic dysfunction-associated steatotic liver disease: SIRT1 deficiency triggers the activation of the NF-κB pathway, leading to increased expression of inflammatory factors like IL-1β, IL-6, and TNF-α, accelerating the progression of NAFLD from simple steatosis to steatohepatitis (Schug et al., 2010).